Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Lentiviral vectors for expression of hepatitis B virus (HBV) antigens

Lentiviral vectors for expression of hepatitis B virus (HBV) antigens

US Patent 10864265 · Granted Dec 15, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Viral vector constructs for expression of genetic adjuvants activating the CD40 2023
Viral vector constructs for expression of genetic adjuvants activating the STING2023
Antigens and vaccines directed against human enteroviruses2020
Antigens and vaccines directed against human enteroviruses2020
Antigens and vaccines directed against human enteroviruses2018
Lentiviral vectors containing an MHC class I, MHC class II, or B2 microglobulin 2017
Lentiviral vectors containing an MHC class I promoter2015
Methods to increase transgene expression from bacterial-based delivery systems b2014
Methods to increase transgene expression from bacterial-based delivery systems b2013
Methods to increase transgene expression from bacterial-based delivery systems b2011
Methods to increase transgene expression from bacterial-based delivery systems b2009